IOVA EBITDA Growth
Iovance Biotherapeutics Inc · EBITDA Growth
IOVA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported29.26%period ending
IOVA TTM EBITDA YoY % (74.13% → 29.26%)
Year-over-year change
High-resolution chart · PNG
IOVA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 29.2563% | |
| 8.7872% | |
| -4.6165% | |
| 6.1102% | |
| 12.4858% | |
| 18.212% | |
| 19.0604% | |
| 6.6725% | |
| -2.7501% | |
| -7.0269% | |
| -10.5751% | |
| -11.9568% | |
| -12.8176% | |
| -16.5411% | |
| -16.877% | |
| -21.0902% | |
| -26.9649% | |
| -28.4164% | |
| -24.1724% | |
| -16.2265% | |
| -10.2513% | |
| -10.1105% | |
| -25.5324% | |
| -46.6015% | |
| -57.166% | |
| -68.5185% | |
| -61.5866% | |
| -48.2421% | |
| -50.472% | |
| -43.3599% | |
| -38.4846% | |
| -45.3341% | |
| -35.1519% | |
| -47.5771% | |
| -75.339% | |
| -80.4024% | |
| -131.989% | |
| -133.0827% | |
| -95.3534% | |
| -92.2789% | |
| -78.2864% | |
| -92.0333% | |
| -124.522% | |
| -26.0073% | |
| 25.1051% | |
| 43.9988% | |
| 52.052% | |
| -136.8214% | |
| -2,653.4884% | |
| -675.918% | |
| -6,391.3692% | |
| 21.0334% | |
| 106.5096% | |
| 117.6639% | |
| 98.1692% | |
| 42.6647% | |
| -28.9107% | |
| -1,860.251% | |
| -2,678.2413% | |
| -5,350.7213% | |
| -7,384.9808% | |
| -1,650.1483% | |
| -5,128.6011% | |
| -1,106.908% | |
| -519.0847% | |
| -104.291% | |
| 74.1256% |